Drug Profile
Terbinafine foam
Alternative Names: TerbiFoam; TerbiFoam Emollient; TerbiFoam Waterless; Terbinafine foam - FoamixLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Foamix
- Class Amines; Antifungals; Naphthalenes; Skin disorder therapies; Small molecules
- Mechanism of Action Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Mycoses; Tinea pedis
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 26 Aug 2010 This programme is still in active development
- 12 Sep 2005 Phase-II clinical trials in Tinea pedis in Israel (Topical)